Aaron D. Showalter - Concepedia

Author

Aaron D. Showalter

Eli Lilly (United States)

Also Known As

A. D. Showalter, AARON D. SHOWALTER, Aaron D Showalter, Aaron D. Showalter

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Indiana University – Purdue University Indianapolis Indiana University School of Medicine Ionis Pharmaceuticals (United States)University of Indianapolis

About

Aaron D. Showalter is an author at Eli Lilly (United States) specializing in medicine, endocrinology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	943
2	Cell Biology	5	5	267
3	Natural Sciences	4	4	142
4	Biochemistry	4	4	241
5	Health Sciences	3	3	602

Aaron D. Showalter

Publications

Citations

H-Index

Page 1

	Year	Citations
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist Francis S. Willard, Jonathan D. Douros, M Gabe, JCI Insight PharmacotherapyExperimental PharmacologyInsulin SignalingObesityMolecular Pharmacology	2020	439
Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors Kyle W. Sloop, Julia X.C. Cao, Angela M. Siesky, Journal of Clinical Investigation	2004	210
Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist Takahiro Kawai, Bingfa Sun, Hitoshi Yoshino, Proceedings of the National Academy of Sciences	2020	172
Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides Merrill D. Benson, Barbara Kluve‐Beckerman, Steven R. Zeldenrust, Muscle & Nerve	2006	146
Novel Small Molecule Glucagon-Like Peptide-1 Receptor Agonist Stimulates Insulin Secretion in Rodents and From Human Islets Kyle W. Sloop, Francis S. Willard, Martin Brenner, Diabetes	2010	139
Structural determinants of dual incretin receptor agonism by tirzepatide Bingfa Sun, Francis S. Willard, Dan Feng, Proceedings of the National Academy of Sciences GlycobiologyPharmacotherapyInsulin SignalingGastrointestinal Peptide HormoneMolecular Pharmacology	2022	105
Structural insights into probe-dependent positive allosterism of the GLP-1 receptor Ana B. Bueno, Bingfa Sun, Francis S. Willard, Nature Chemical Biology Molecular PharmacologySignal TransductionMolecular PhysiologyStructural InsightsG Protein-coupled Receptor	2020	91
Allosteric Modulation of Endogenous Metabolites as an Avenue for Drug Discovery Denise Wootten, Emilia E. Savage, Céline Valant, Molecular Pharmacology	2012	78
Progesterone Receptor Membrane Component 1 Is a Functional Part of the Glucagon-like Peptide-1 (GLP-1) Receptor Complex in Pancreatic β Cells Ming Zhang, Mélanie Robitaille, Aaron D. Showalter, Molecular & Cellular Proteomics Cellular PhysiologyInsulin SignalingGastrointestinal Peptide HormoneCell SurfaceReceptor Complex	2014	64
Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles Ana B. Bueno, Aaron D. Showalter, David B. Wainscott, Journal of Biological Chemistry	2016	59

Page 1